These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1103293)

  • 21. Uric acid, joint morbidity, and streptococcal antibodies in Maori and European teenagers. Rotorua Lakes study 3.
    Stanhope JM; Prior IA
    Ann Rheum Dis; 1975 Aug; 34(4):359-63. PubMed ID: 1190855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facilitating equitable prevention and management of gout for Māori in Northland, New Zealand, through a collaborative primary care approach.
    Lawrence A; Scott S; Saparelli F; Greville G; Miller A; Taylor A; Gow P
    J Prim Health Care; 2019 Jul; 11(2):117-127. PubMed ID: 32171354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperuricemia and gout.
    Pennes DR; Martel W
    Semin Roentgenol; 1986 Oct; 21(4):245-55. PubMed ID: 3538425
    [No Abstract]   [Full Text] [Related]  

  • 24. The Maoris of New Zealand: a historical view of culture and family.
    Brown HN
    Health Care Women Int; 1991; 12(4):407-14. PubMed ID: 1955406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in colorectal cancer incidence and histologic findings in Maori and Polynesian residents of New Zealand.
    Sutton TD; Eide TJ; Jass JR
    Cancer; 1993 Jun; 71(12):3839-45. PubMed ID: 8389651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sugar-sweetened beverages, urate, gout and genetic interaction.
    Merriman TR; Dalbeth N; Johnson RJ
    Pac Health Dialog; 2014 Mar; 20(1):31-8. PubMed ID: 25928993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of urinary albumin excretion between Maoris, Pacific Island Polynesians and Europeans with non-insulin-dependent diabetes.
    Lunt H; Lim CW; Crooke MJ; Smith RB
    Diabetes Res Clin Pract; 1990 Jan; 8(1):45-9. PubMed ID: 2298119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes in New Zealand.
    Moore MP; Lunt H
    Diabetes Res Clin Pract; 2000 Oct; 50 Suppl 2():S65-71. PubMed ID: 11024586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption.
    Rasheed H; Phipps-Green A; Topless R; Hollis-Moffatt JE; Hindmarsh JH; Franklin C; Dalbeth N; Jones PB; White DH; Stamp LK; Merriman TR
    Arthritis Res Ther; 2013 Nov; 15(6):R177. PubMed ID: 24286387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some unusual features of gouty arthritis in females.
    Yü TF
    Semin Arthritis Rheum; 1977 Feb; 6(3):247-55. PubMed ID: 835022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of Rheumatic disorders in the Pacific with particular emphasis on hyperuricaemia and gout.
    Prior L
    Semin Arthritis Rheum; 1981 Aug; 11(1):213-29. PubMed ID: 6974401
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets.
    Hollis-Moffatt JE; Xu X; Dalbeth N; Merriman ME; Topless R; Waddell C; Gow PJ; Harrison AA; Highton J; Jones PB; Stamp LK; Merriman TR
    Arthritis Rheum; 2009 Nov; 60(11):3485-92. PubMed ID: 19877038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gouty nephropathy: fact or fiction?
    Porter GA
    Am J Kidney Dis; 1983 Mar; 2(5):553-4. PubMed ID: 6338709
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout.
    McKinney C; Stamp LK; Dalbeth N; Topless RK; Day RO; Kannangara DR; Williams KM; Janssen M; Jansen TL; Joosten LA; Radstake TR; Riches PL; Tausche AK; Lioté F; So A; Merriman TR
    Arthritis Res Ther; 2015 Oct; 17():288. PubMed ID: 26462562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review of the prevalence of gout and hyperuricaemia in Australia.
    Robinson PC; Taylor WJ; Merriman TR
    Intern Med J; 2012 Sep; 42(9):997-1007. PubMed ID: 24020339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol.
    Ofanoa M; Ofanoa SM; Heather M; Tu'akoi S; Lutui H; Dalbeth N; Grey C; van der Werf B; Goodyear-Smith F
    Int J Equity Health; 2021 Dec; 20(1):262. PubMed ID: 34949187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1A.
    Cadzow M; Merriman TR; Boocock J; Dalbeth N; Stamp LK; Black MA; Visscher PM; Wilcox PL
    BMC Med Genet; 2016 Nov; 17(1):80. PubMed ID: 27846814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperuricaemia, gout, and diabetic abnormality in Polynesian people.
    Prior IA; Rose BS; Harvey HP; Davidson F
    Lancet; 1966 Feb; 1(7433):333-8. PubMed ID: 4159475
    [No Abstract]   [Full Text] [Related]  

  • 39. The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity.
    Hollis-Moffatt JE; Gow PJ; Harrison AA; Highton J; Jones PB; Stamp LK; Dalbeth N; Merriman TR
    Arthritis Res Ther; 2011 Jun; 13(3):R85. PubMed ID: 21658257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology of uric acid and fructose.
    Rho YH; Zhu Y; Choi HK
    Semin Nephrol; 2011 Sep; 31(5):410-9. PubMed ID: 22000647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.